
Sign up to save your podcasts
Or


Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, direct payments.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By CNBC4.1
542542 ratings
Jim Cramer and David Faber discuss Wall Street’s tough September, stocks on pace for their fourth straight weekly loss, for the first time in more than a year. Plus signs of hope for a COVID-19 vaccine, Novavax starting a phase 3 trial & Sanofi predicting one billion doses produced globally by early next year. And House Democrats preparing a new $2.4 trillion stimulus plan with unemployment aid, direct payments.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

4,090 Listeners

3,221 Listeners

1,353 Listeners

240 Listeners

152 Listeners

522 Listeners

326 Listeners

67 Listeners

155 Listeners

1,037 Listeners

33 Listeners

354 Listeners

45 Listeners

2,151 Listeners

5 Listeners

556 Listeners

20 Listeners

1,563 Listeners

213 Listeners

410 Listeners

300 Listeners

119 Listeners

825 Listeners

174 Listeners

34 Listeners

10 Listeners

56 Listeners

29 Listeners

9 Listeners

16 Listeners

2 Listeners